Document Detail


Hepatic TRAF2 Regulates Glucose Metabolism Through Enhancing Glucagon Responses.
MedLine Citation:
PMID:  22315325     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Obesity is associated with intrahepatic inflammation that promotes insulin resistance and type 2 diabetes. Tumor necrosis factor receptor-associated factor (TRAF)2 is a key adaptor molecule that is known to mediate proinflammatory cytokine signaling in immune cells; however, its metabolic function remains unclear. We examined the role of hepatic TRAF2 in the regulation of insulin sensitivity and glucose metabolism. TRAF2 was deleted specifically in hepatocytes using the Cre/loxP system. The mutant mice were fed a high-fat diet (HFD) to induce insulin resistance and hyperglycemia. Hepatic glucose production (HGP) was examined using pyruvate tolerance tests, (2)H nuclear magnetic resonance spectroscopy, and in vitro HGP assays. The expression of gluconeogenic genes was measured by quantitative real-time PCR. Insulin sensitivity was analyzed using insulin tolerance tests and insulin-stimulated phosphorylation of insulin receptors and Akt. Glucagon action was examined using glucagon tolerance tests and glucagon-stimulated HGP, cAMP-responsive element-binding (CREB) phosphorylation, and expression of gluconeogenic genes in the liver and primary hepatocytes. Hepatocyte-specific TRAF2 knockout (HKO) mice exhibited normal body weight, blood glucose levels, and insulin sensitivity. Under HFD conditions, blood glucose levels were significantly lower (by >30%) in HKO than in control mice. Both insulin signaling and the hypoglycemic response to insulin were similar between HKO and control mice. In contrast, glucagon signaling and the hyperglycemic response to glucagon were severely impaired in HKO mice. In addition, TRAF2 overexpression significantly increased the ability of glucagon or a cAMP analog to stimulate CREB phosphorylation, gluconeogenic gene expression, and HGP in primary hepatocytes. These results suggest that the hepatic TRAF2 cell autonomously promotes hepatic gluconeogenesis by enhancing the hyperglycemic response to glucagon and other factors that increase cAMP levels, thus contributing to hyperglycemia in obesity.
Authors:
Zheng Chen; Liang Sheng; Hong Shen; Yujun Zhao; Shaomeng Wang; Robert Brink; Liangyou Rui
Related Documents :
2694325 - Fasting for 72 h decreases the responses of counterregulatory hormones to insulin-induc...
19900235 - Plasma glucose and hypoglycaemia following exercise in people with type 1 diabetes: a c...
503565 - Physiological responses to insulin hypoglycaemia in spinal man.
15551045 - Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children...
21604995 - Intrapartum cardiotocography (ctg) and st-analysis of labor in diabetic patients.
1743805 - Influence of type i and type ii diabetes mellitus on phenytoin steady-state levels.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-7
Journal Detail:
Title:  Diabetes     Volume:  -     ISSN:  1939-327X     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-8     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372763     Medline TA:  Diabetes     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, Michigan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Age-Related Impairment in Insulin Release: The Essential Role of ?2-Adrenergic Receptor.
Next Document:  Tracheal intubation in the critically ill: a multi-centre national study of practice and complicatio...